Polymyositis during pegylated alpha-interferon ribavirin therapy for chronic hepatitis.
John
Anil
A
El Emadi
Samar
S
Al Kaabi
Saad
S
Morad
Nader
N
Derbala
Moutaz
M
Yakoub
Rafie
R
Dweik
Nazeeh
N
Butt
Mohammed Tariq
MT
D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications / Q000178:diet therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D017285:Polymyositis / Q000139:chemically induced*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a